Lighting the Way to a Cure

  • Financials
  • Patient Library
  • Blog
  • Calendar
FSHD Header Logo
mobile-logo

  • Who We Are
        • About Us
          • History
          • Mission
          • Our Team
          • Financials
        • Our Impact
          • Therapeutic Accelerator
          • Education
          • Advocacy
          • Our Partners
        • Journey To A Cure
          • 2022 Donor Impact Report
  • Understanding FSHD
        • What is FSHD
          • Symptoms
          • Diagnosis
          • Early-onset FSHD
          • Genetic Testing
        • Living with FSHD
          • Newly Diagnosed?
          • Finding Care
          • Symptom Management
          • Patient Library
        • FSHD University
          • Physical Health
          • Wellness
          • Research
  • Get Involved
        • Support Us
          • Ways to Give
          • Become a Torchbearer
          • Raise Awareness
          • Volunteer
          • Fundraise
        • Advance Research
          • What is a Clinical Trial?
          • Your Involvement Matters
          • Current Trials & Studies
        • Connect
          • Find Your Local Chapter
          • Join the Community
          • World FSHD Alliance
          • Online Communities
        • Events
          • Walk & Roll to Cure FSHD
          • Events Calendar
          • FSHD 360 Regional Conferences
          • World FSHD Day
  • Research
        • For Patients & Families
          • Advance Research
          • True Cost of FSHD Study
          • TestFSHD genetic testing
          • Current Trials and Studies
        • For Researchers
          • Apply for a Grant
          • Research We Have Funded
          • Resources
          • Int’l Research Congress
        • For Clinicians
          • FSHD Masterclass
          • ICD-10
        • For Industry
          • Therapeutic Accelerator
          • Clinical Trial Research Network
          • Drug Development Pipeline
          • Voice of the Patient Report
          • Project Mercury
  • News
    • Media Library
    • Blog
      • Living with FSHD
        • Health and Medicine
        • PT and Exercise
        • Tips and Tricks
        • Mental Health
      • FSHD Society News
      • FSHD Research
      • Fundraising & Events
      • Media & PR
    • FSHD Society Radio
    • The FSHD Advocate
  • Search
  • Financials
  • Patient Library
  • Blog
  • Calendar
  • JOIN US
  • Donate
  • JOIN US
  • Donate

The Future is Now for the Voice of the Patient

Home / FSHD Research / The Future is Now for the Voice of the Patient

Posted on: Dec 05, 2019

The Future is now At the end of the day, if there were a drug that stopped FSHD in its tracks, would you want it, even if it did not restore what you have already lost? What if a drug made you stronger temporarily, even if it did not stop the disease? Only those who are directly affected by FSHD—the patients, family members, caregivers—can say what is a meaningful benefit and acceptable risk of a therapy. The “voice of the patient” in these matters carries great weight with the Food and Drug Administration (FDA) when it considers an application by a drug company to put a new therapy on the market.

The FSHD Society’s Patient Focused Drug Development (PFDD) meeting, scheduled for April 21, 2020, is our forum to present testimony by patients and family caregivers to the FDA. This is your chance to educate the FDA on how FSHD has impacted your life or the life of your loved ones. It also provides an opportunity for you to describe what is most important and how a successful therapy could improve your quality of life. The resulting Voice of the Patient report will be published and submitted to the FDA’s Division of Neurology Products, Office of New Drugs, for inclusion in the framework used to evaluate future FSHD therapies. The FDA will use that information as it evaluates the potential benefits and risks of a therapy to the FSHD patient community.

Join our registry

Our PFDD is a milestone event to gather and summarize input from patients across the country, so we encourage everyone, at every stage of disease progression, to get involved, whether through in-person attendance at the meeting, on-line attendance and voting, or through participation in surveys we will send out to gather data prior to the meeting.

The Patient-Focused Drug Development is a key initiative of our 2020 FSHD Therapeutics Accelerator, and another way the FSHD Society is working to get treatments to you faster.

 

Share

Filed Under: FSHD Research

Comments

  1. SHIRLEY L. SNELSON says

    December 5, 2019 at 11:11 am

    I am a late onset symptomatic FSHD person, will be turning 71 soon. At the least I would like this to be stopped in it’s progression. Reversal would be great, probably not in my lifetime though. This condition has taken away a good deal of independence that I was used to up until 2010. I saw my Mother progress to being wheelchair bound, I’m fighting that. She lived to be 90, and I live in fear that that will be my fate as well. She hated it, not really knowing what it was taking away her ability to just use the bathroom by herself.

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

SEARCH

Categories

  • FSHD Research
  • FSHD Society News
    • Extraordinary Measures
    • Journey to a Cure
  • Fundraising & Events
  • General
  • Living with FSHD
    • Health and Medicine
    • Mental Health
    • PT and Exercise
    • Tips and Tricks
  • Media & PR

Sign up for Email Alerts

Stay up to date with the latest FSHD news and updates from FSHD Society.

CONNECT WITH US

Proud Member World FSHD Alliance (1)
Footer-Logo-min

General Mailing Address:

75 North Main Street, Suite 1073
Randolph, MA 02368 U.S.A.

Mail Donations to:

FSHD Society
P.O. Box 411617
Boston, MA 02241-1617

(781) 301-6060

  • DONATE
  • Donate
  • Join Us
  • Inclusivity & Equity
  • Privacy Policy
  • Contact Us
  • Glossary Of Scientific Terms
Digital Marketing by